Skip to main content
Premium Trial:

Request an Annual Quote

Primera Biosystems Closes $11M Stock Placement

NEW YORK, July 15 (GenomeWeb News) - Primera Biosystems announced this week that it has closed an $11 million placement of stock to a group of investors including MPM Capital, Burrill and Company, and the Malaysian Technology Development Corporation.

 

The company said the financing will enable it to develop both instrument systems and disease-specific diagnostic reagent kits for commercialization.

 

Primera is developing a gene expression analysis system called STAR (Scalable Transcription Analysis Routine) that combines features of real-time PCR and DNA microarray technologies.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.